Losartan potassium - test formulation
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Losartan potassium - test formulation, covering 2017-10-25 to 2017-10-25. Get the full timeline:
Most recent: Clinical Trial Update: Bioequivalence Study of Losartan Potassium (100 mg Tablet) [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Cozaar® (100 mg Tablet) [Reference Formulation, Merck & Co. Inc., USA] in Healthy Human Volunteers Under Fasting Condition [Phase 1]